In the 60s Slovenia’s winter services used zeolite instead of salt. In lack of own infrastructure the government services contracted local farmers to store the minerals. And so it happened that one day a few tons of zeolite overstrained the ceiling structure of a stable and landed in the pigs barn. When the farmer came to see the animals next morning he was surprised to find them eating the volcanic ash minerals derived from marine sediments for breakfast. He underwent a few days of anxious waiting, but the pigs did well. Eerily well.
That was the beginning of the medical use of zeolite in Europe. Hooking on developments from the former Soviet Union, the Croatian researcher Tihomir Lelas had the next go at the topic. Zeolite was until then been valued as a healing earth mainly because of its large ion-exchange capacity, but the Soviets had launched a new grinding process to the starting line, where the rock powder was micronized and also electrically charged in a single operation.
With Lelas this tribomechanically Activated Zeolite (TMAZ) found its way to the Patent and Trademark Office. After being activated, the healing earth now interfered with the electrochemistry of the body by neutralizing free radicals – in a particularly intense way due to the micronized particles being partially cell-permeable and thus able to deploy their effect anywhere in the body. The first manufacturer to reach a larger market presence was Lela’s partner Milan Ljubicic. The product was distributed from Berlin under the name Megamin (for humans) and Mega Green (as a foliar fertilizer for plants). Ljubicic was ambitious. He wanted to legally establish the miracle cure for approval as a drug. This adventure cost him about 10 million € invest and finally his existence as a company. After a total of about 70 legal proceedings launched by the pharmaceutical industry against him, he was too broke to release the clinical studies from the hospitals that conducted them. Unfortunately.
Among other things, Megamin was tested in numerous clinical preliminary studies on cancer patients as adjunctive therapy to radiation and chemotherapy, and in a parallel experiment as an alternative to radiotherapy and chemotherapy.  81% of the patients treated with TMAZ only completely recovered after three years, 19% of patients at least showed some improvement of their health. With the group that received radiation and chemotherapy in parallel the therapeutic success was nevertheless still at 50%, while the other half had only some improvement in their health condition. None of the patients had died. Without the application of TMAZ the chance of survival (5 years) after having a chemotherapy in long-term average lies between 0.7 to 2.3%. Depending on the type of cancer.
However, the cancer therapy is by far not the only use of zeolite. Zeolite consists of aluminum oxide and silicon oxide forming an extremely porous crystalline structure. 50% of the volume is built up by voids and capillaries. Due to the fineness of the structure the crystal has an internal surface of 500-600 square meters per gram. Being formed in sea water by the ash from volcanoes mounting up to sediments, large quantities of minerals are bound into the zeolite crystal structure. Thus zeolite doesn’t only show large ion exchange capacities, but also keeps exactly those minerals at hand that are needed to balance the mineral equilibrium in the cell water. The only exception being in main components aluminum oxide and silicon oxide, where Zeolites rich in silicates are preferred because of their higher ability to divert aluminum compounds and thus in particular seem to be able to prevent Alzheimer’s disease.
The list of diseases responding positively to zeolite is sufficiently long. According to the cited summary by Lelas positive results were obtained in studies of the
- Immunostimulatory effect
- Testing of anti-oxidative effect
- Testing of adjuvant effect (p21 and p27) in tumor cell models.
- Testing of effect on viruses
- Testing of effect on cell receptors
- Morphological and functional changes of micro vascular systems and the immune system of small intestine
- Effect on cell medium and resultant effect on tumor cells
- Testing in cases of intensifying reactive abilities and biological activities in combination with other substances
After the collapse of the Megamin company it was difficult for a while to get tribomechanically activated zeolite as a dietary supplement. By now despite of a few open questions concerning the trademark TMAZ the activated material is available again. The non-activated qualities have prevailed in the treatment of fat stock where zeolite is used in the production of animal feed – however being declared as an anti-caking agent.